Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
Men and women with suspected or proven genital infections caused by Chlamydia trachomatis were enrolled in a double-blind study to evaluate the efficacy and tolerability of fleroxacin. Patients received either 400, 600, or 800 mg once daily for 7 days and were monitored approximately 2, 4, and 7 wee...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1989
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2511801/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.10.1774 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|